BACKGROUND: A variant in steroidogenic factor-1 (SF-1, encoded by the gene NR5A1), p.Arg92Trp, has recently been reported in multiple families with 46,XX ovotesticular or testicular disorders of sex development (DSD). This amino acid change impacts the DNA-binding domain and perturbs gonadal differentiation pathways. METHODS: Whole-exome sequencing was performed on a 46,XX subject with ovotesticular DSD. RESULTS: Exome results identified a heterozygous NR5A1 variant, p.Arg92Gln, in the 46,XX ovotesticular DSD proband. This arginine-to-glutamine change has been previously reported in the homozygous state in a 46,XY patient with gonadal and adrenal dysgenesis, though 46,XY and 46,XX heterozygous carriers of this variant have not been previously reported to have any clinical phenotype. CONCLUSIONS: The NR5A1 p.Arg92Gln variant, which has thus far only been seen in a family with 46,XY DSD, most likely contributes to the ovotesticular DSD in this case. In light of the recent reports of unrelated 46,XX subjects with testicular or ovotesticular DSD with the NR5A1 variant p.Arg92Trp, it appears that other mutations in the DNA binding domain have the potential to impact the factors determining testicular and ovarian differentiation. This case demonstrates the variability of phenotypes with the same genotype and broadens our understanding of the role of SF-1 in gonadal differentiation.
BACKGROUND: A variant in steroidogenic factor-1 (SF-1, encoded by the gene NR5A1), p.Arg92Trp, has recently been reported in multiple families with 46,XX ovotesticular or testicular disorders of sex development (DSD). This amino acid change impacts the DNA-binding domain and perturbs gonadal differentiation pathways. METHODS: Whole-exome sequencing was performed on a 46,XX subject with ovotesticular DSD. RESULTS: Exome results identified a heterozygous NR5A1 variant, p.Arg92Gln, in the 46,XX ovotesticular DSD proband. This arginine-to-glutamine change has been previously reported in the homozygous state in a 46,XY patient with gonadal and adrenal dysgenesis, though 46,XY and 46,XX heterozygous carriers of this variant have not been previously reported to have any clinical phenotype. CONCLUSIONS: The NR5A1 p.Arg92Gln variant, which has thus far only been seen in a family with 46,XY DSD, most likely contributes to the ovotesticular DSD in this case. In light of the recent reports of unrelated 46,XX subjects with testicular or ovotesticular DSD with the NR5A1 variant p.Arg92Trp, it appears that other mutations in the DNA binding domain have the potential to impact the factors determining testicular and ovarian differentiation. This case demonstrates the variability of phenotypes with the same genotype and broadens our understanding of the role of SF-1 in gonadal differentiation.
Authors: Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo Journal: Genome Res Date: 2010-07-19 Impact factor: 9.043
Authors: Lin Lin; Pascal Philibert; Bruno Ferraz-de-Souza; Daniel Kelberman; Tessa Homfray; Assunta Albanese; Veruska Molini; Neil J Sebire; Silvia Einaudi; Gerard S Conway; Ieuan A Hughes; J Larry Jameson; Charles Sultan; Mehul T Dattani; John C Achermann Journal: J Clin Endocrinol Metab Date: 2007-01-02 Impact factor: 5.958
Authors: Geraldine A Van der Auwera; Mauricio O Carneiro; Christopher Hartl; Ryan Poplin; Guillermo Del Angel; Ami Levy-Moonshine; Tadeusz Jordan; Khalid Shakir; David Roazen; Joel Thibault; Eric Banks; Kiran V Garimella; David Altshuler; Stacey Gabriel; Mark A DePristo Journal: Curr Protoc Bioinformatics Date: 2013
Authors: Ruth M Baxter; Valerie A Arboleda; Hane Lee; Hayk Barseghyan; Margaret P Adam; Patricia Y Fechner; Renee Bargman; Catherine Keegan; Sharon Travers; Susan Schelley; Louanne Hudgins; Revi P Mathew; Heather J Stalker; Roberto Zori; Ora K Gordon; Leigh Ramos-Platt; Anna Pawlikowska-Haddal; Ascia Eskin; Stanley F Nelson; Emmanuèle Délot; Eric Vilain Journal: J Clin Endocrinol Metab Date: 2014-11-10 Impact factor: 5.958
Authors: Jonathan M Swartz; Ryan Ciarlo; Michael H Guo; Aser Abrha; David A Diamond; Yee-Ming Chan; Joel N Hirschhorn Journal: Horm Res Paediatr Date: 2016-08-24 Impact factor: 2.852
Authors: Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev Journal: Nat Methods Date: 2010-04 Impact factor: 28.547
Authors: Anu Bashamboo; Patricia A Donohoue; Eric Vilain; Sandra Rojo; Pierre Calvel; Sumudu N Seneviratne; Federica Buonocore; Hayk Barseghyan; Nathan Bingham; Jill A Rosenfeld; Surya Narayan Mulukutla; Mahim Jain; Lindsay Burrage; Shweta Dhar; Ashok Balasubramanyam; Brendan Lee; Marie-Charlotte Dumargne; Caroline Eozenou; Jenifer P Suntharalingham; Ksh de Silva; Lin Lin; Joelle Bignon-Topalovic; Francis Poulat; Carlos F Lagos; Ken McElreavey; John C Achermann Journal: Hum Mol Genet Date: 2016-07-04 Impact factor: 6.150
Authors: L Audi; S F Ahmed; N Krone; M Cools; K McElreavey; P M Holterhus; A Greenfield; A Bashamboo; O Hiort; S A Wudy; R McGowan Journal: Eur J Endocrinol Date: 2018-10-01 Impact factor: 6.664
Authors: Ingrid M Knarston; Gorjana Robevska; Jocelyn A van den Bergen; Stefanie Eggers; Brittany Croft; Jason Yates; Remko Hersmus; Leendert H J Looijenga; Fergus J Cameron; Klaus Monhike; Katie L Ayers; Andrew H Sinclair Journal: Hum Mutat Date: 2018-11-30 Impact factor: 4.878
Authors: Jocelyn A van den Bergen; Gorjana Robevska; Stefanie Eggers; Stefan Riedl; Sonia R Grover; Philip B Bergman; Chris Kimber; Ashish Jiwane; Sophy Khan; Csilla Krausz; Jamal Raza; Irum Atta; Susan R Davis; Makato Ono; Vincent Harley; Sultana M H Faradz; Andrew H Sinclair; Katie L Ayers Journal: Mol Genet Genomic Med Date: 2020-01-21 Impact factor: 2.183